Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 9, 2007, Pages 3547-3552

  Marković, Vinko ^a   Eterović, Davor ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; RADIOACTIVE IODINE; THIAMAZOLE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; SEX RATIO; THYROID GLAND; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 34548776059     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0879     Document Type: Article

References (31)

1. Woeber KA 1986 Graves' disease: general considerations. In: Ingbar SH, Braverman LE, eds. Werner's the thyroid: a fundamental and clinical text. 5th ed. Philadelphia: Lippincott; 982-986
2. Vitti P, Rago R, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A 1997 Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7:369-375
3. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM 1995 Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile? Clin Endocrinol (Oxf) 43:325-329
4. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC 1991 Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 34:71-76
5. Nordyke RA, Gilber Jr FI 1991 Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 32:411-416
6. Watson AB, Brownlie BE, Frampton CM, Turner JG, Rogers TG 1988 Outcome following standardized 185 MBq dose 131I therapy for Graves' disease. Clin Endocrinol (Oxf) 28:487-496
7. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H 1997 Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized trial. Thyroid 7:247-251
8. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A 1998 Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab 83:40-46
9. Haase A, Bähre M, Lauer I, Meller B, Richter E 2000 Radioiodine therapy in Graves' hyperthyroidism: determination of the individual optimum target dose. Exp Clin Endocrinol Diabetes 108:133-137
10. Körber C, Schneider P, Körber-Hafner N, Hänscheid H, Reiners C 2001 Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goiter? Eur J Nucl Med 28:1360-1364
11. Howarth D, Epstein M, Lan L, Tan P, Booker J 2001 Determination of optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Eur J Nucl Med 28:1489-1495
12. Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, Krause TM 2002 Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med 29:1118-1124
13. Bajnok L, Mezosi E, Nagy E, Szabo J, Sztojka I, Varga J, Galuska L, Leovey A 1999 Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary? Thyroid 9:865-869
14. Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SCL, Franklyn JA 2000 Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab 85:1038-1042
15. Allahabadia A, Daykin J, Sheppard MC, Gough SCL, Franklyn JA 2001 Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 86:3611-3617
16. Yamashita Y, Yamane K, Tamura T, Okubo M, Kohno N 2004 Onset age is associated with outcome in radioiodine therapy of Graves' disease. Endocr J 51:127-132
17. Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, Buell U 1999 Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. J Clin Endocrinol Metab 84:1229-1233
18. Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U 1999 Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid 9:1181-1188
19. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T 1997 The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf) 47:425-430
20. Tuttle RM, Patience T, Budd S 1995 Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive radioiodine alone in Graves' disease. Thyroid 5:243-247
21. Concato J, Feinstein AR, Holford TR 1993 The risk of determining risk with multivariate models. Ann Intern Med 118:201-210
22. Müller HW, Schröder S, Schneider C, Seifert G 1985 Sonographic tissue characterisation in thyroid gland diagnosis. A correlation between sonography and histology. Klin Wochenschr 63:706-710
23. Zingrillo M, D'Aloiso L, Ghiggi MR, Di Cerbo A, Chiodini I, Torlontano M, Liuzzi A 1996 Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence? Clin Endocrinol (Oxf) 45:201-206
24. Marinelli LD 1949 Dosage determination in the use of radioactive isotopes. J Clin Invest 28(6 Pt 1):1271-1280
25. Zhang J, Yu KF 1998 What's the relative risk: a method of correcting odds ratio in cohort studies of common outcomes. JAMA 280:1690-1691
26. Vitti P, Rago T, Mancusi F, Pallini S, Tonacchera M, Santini F, Chiovato L, Marcocci C, Pinchera A 1992 Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 126:128-131
27. Andrade VA, Gross JL, Maia AL 2001 The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one year follow up of a prospective randomized study. J Clin Endocrinol Metab 86:3488-3493
28. Halmi NS 1986 Anatomy and histochemistry. In: Ingbar SH, Braverman LE, eds. Werner's the thyroid: a fundamental and clinical text. 5th ed. Philadelphia: Lippincott; 24-36
29. Maxon HR, Saenger EL 2000 Biologic effects of radioiodines on the human thyroid gland. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott; 345-354
30. Oertel JE, LiVolsi VA 1986 Pathology of thyroid diseases In: Ingbar SH, Braverman LE, eds. Werner's the thyroid: a fundamental and clinical text. 5th ed. Philadelphia: Lippincott; 651-686.
31. Kusic Z, Novosel SA, Dabelic N, Punda M, Roncevic S, Labar Z, Lukinac LJ, Nothig-Hus D, Stanicic A, Kaic-Rak A, Mesaros-Kanjski E, Karner I, Smoje J, Milanovic N, Katalenic M, Juresa V, Sarnavka V 2003 Croatia has reached iodine sufficiency. J Endocrinol Invest 26:738-742